ICOS and ICOS ligand: expression patterns and outcomes in oncology patients
Background: Inducible T-cell co-stimulator (ICOS) and its ligand (ICOSL) form a complex, two-faced immune machinery that can lead to both immune stimulation and inhibition. Objective: We explored ICOS transcriptomic expression patterns and their relationship with other checkpoints and with outcomes...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251330514 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|